Day 1: Monoclonal Antibody Drugs (MABs) were first generated in the 1970s and were first licensed in the 1980s for transplant rejection. The advancing technology in the 1990s led to improved B cell...
The UK government has announced a new initiative to make hormone replacement therapy (HRT) more affordable for women experiencing symptoms of menopause. The move is expected to benefit hundreds of...
With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice, you can earn your 1-hour CPD certificate .
NICE has recommended a weekly injection for treating growth failure in children. The recommended treatment, known as growth hormone therapy, involves a weekly injection of a hormone called somatropin....
Day 1: In the 1990s, growing insight into incretin roles in type 2 (T2DM) diabetes led to an interest in the breakdown of gut hormone GLP-1. DPP-4 was identified as the best peptidase target and a...
Following the announcement of serious shortage protocols (SSPs) on Thursday, December 15, five new SSPs have been issued..
Day 1: The discovery of the COX-2 channel in the early 1990s led to two new NSAIDs designed and licensed with COX-2 selective action. The new drug target implied therapeutic and adverse drug effect...
The batches shown in Table 1 of Targocid 200 mg powder for injection/infusion or oral solution are being recalled immediately by Sanofi UK. This is due to out of specification results for bacterial...
Following the publication of final draught National Institute for Health and Care Excellence (NICE) guidance on 23 September 2022, approximately 1500 people aged 12 years and older with melanoma are...
With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice, you can earn your 1-hour CPD certificate .
Following a deal with the manufacturer of Dexcom One, patients with type 1 diabetes in England are now eligible for continuous glucose monitors (CGMs). Until recently, the only CGMs widely available...
The National Institute of Health and Care Excellence (NICE) has published final draft guidance recommending icosapent ethyl to reduce the risk of cardiovascular events such as heart attacks and...
Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.
Evidence-based best practice
Drug updates
Pharmacology information
Calculation skills